Prostate cancer is the most commonly diagnosed cancer in men. Prostate MRI is currently the most precise method for determining possible changes. Multiparametric imaging of the prostate makes it possible to detect prostate cancer at an early stage, to rule out its presence with a high degree of certainty or to assess the aggression of a tumor. The patient is given an intravenous MR contrast agent before the examination, which increases the informative value of the examination and confirms the diagnosis. Thanks to the latest technology, the required amount of contrast agent can be significantly reduced. Please note our contrast agent information sheets.
Exclusion or evidence of prostate cancer
Gaalerstraße 2a, 8720 Knittelfeld, AUSTRIA
07.30 am - 04.30 pm
07.30 am - 01.00 pm